SBIR/STTR Research Award
Screening Assay for Platelet ADP Receptor Antagonists
Award amount
$85,575Program and phase
SBIR · Phase IAward year
1995Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- COR THERAPEUTICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
ADP activates and promotes aggregation of platelets in hemostasis and thrombosis. This applicationdevelop a high-throughput screening assay to identify novel ADP-receptor antagonists. The assay willof a high-affinity radioligand to using 96-well microtiter plates. The assay will be validated for ssynthetic compounds. This assay may lead to a Phase II proposal for the performance of high-throughpidentification and characterization of ADP receptor antagonists. Based on this lead, novel orally acmay be developed for the prevention and treatment of cardiovascular diseases.
Technology keywords
Not reported